Welcome to our dedicated page for Darling Ingred news (Ticker: DAR), a resource for investors and traders seeking the latest updates and insights on Darling Ingred stock.
Darling Ingredients Inc. reports developments in its global ingredients and renewable energy business, which collects animal agriculture and food-industry residuals and converts them into feed ingredients, food ingredients, collagen products, fats, fertilizers, renewable fuels, biogas and energy products.
Recurring company news includes quarterly and annual results, segment performance, updates on the Diamond Green Diesel renewable fuels joint venture, production tax credit sales, portfolio realignment, capital spending, debt and liquidity, investor-day strategy, and board governance matters.
Darling Ingredients Inc. (NYSE: DAR) will host a conference call on August 6, 2020, at 9:00 a.m. ET to discuss its Q2 2020 financial results. The call will feature CEO Randall Stuewe and CFO Brad Phillips. A slide presentation will accompany the call, accessible through the investor relations section of the company’s website. The related press release will be issued after market close on August 5, 2020. Participants can pre-register for the call or dial in directly, with options for both U.S. and international callers.
Darling Ingredients Inc. (NYSE: DAR) announced the launch of X-Pure® GelMA at Bio Digital 2020, marking the introduction of the first GMP-ready gelatin methacryloyl biomaterials suitable for clinical applications. This ultra-pure solution addresses the limitations of standard GelMA products, featuring low levels of impurities that can affect in-body and in vitro applications. With its unique two-stage purification process, X-Pure® GelMA promises consistent quality and safety, supporting 3D bioprinting and regenerative medicine. The product is poised to meet the growing needs of the biomedical sector.
Darling Ingredients Inc. (NYSE: DAR) announced the commissioning of a new collagen peptides production facility in Ghent, Belgium. This facility exclusively produces porcine collagen and is part of Rousselot's strategy to expand global hydrolyzed collagen production. With the first commercial batches ready for delivery in July, the facility enhances Rousselot's capabilities alongside existing operations in Brazil and France. Additionally, construction continues for a new facility in Brazil, expected to be completed in October 2020, further solidifying Darling's position in the collagen market.